A practical reference on nitric oxide system: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-10-02 and is reviewed periodically as new material appears.
Proposed mechanisms in the literature involve the nitric oxide system, vascular endothelial growth factor signaling, and epidermal growth factor receptor pathways. Some studies report changes in blood vessel formation or in inflammatory mediators, while others describe interactions with nervous tissue. Much of this evidence rests on molecular markers in cultured cells or animal models. Whether the same pathways operate the same way in humans has not been established. Authors therefore tend to describe mechanisms as hypothetical rather than settled.
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
Most published reports describe experiments in rodents rather than in people. These studies examine outcomes in tendons, ligaments, bone, stomach lining, and intestinal tissue. In rat and mouse models, a frequently reported effect is faster healing or reduced damage. Sample sizes are usually small, and a substantial share of the work originates from a small number of research groups. Independent replication is limited, so how far the findings extend to humans remains an open question.
BPC-157 is normally distributed as a lyophilised powder that ranges from white to off-white in appearance. The peptide dissolves readily in water, normal saline, and common aqueous buffers, and it is poorly soluble in nonpolar solvents such as hexane or vegetable oils. Lyophilised vials take up moisture if left open, which changes the mass of powder in the container and complicates any later weighing. Because the material is handled in small quantities, static and adhesion to glass or plastic can also cause noticeable losses during transfer.
The main chemical liabilities of this sequence are peptide-bond hydrolysis and possible aspartate-related reactions, since the peptide contains aspartic acid residues but no cysteine, methionine, or tryptophan. Absence of those three residues removes the most common oxidation and disulfide pathways from consideration. Studies of related peptides indicate that aspartate isomerisation and aspartimide formation occur most readily at Asp-Gly and Asp-Ala positions, and open questions remain about how quickly those reactions proceed under ordinary laboratory conditions. Storage guidance typically emphasises cool, dry, dark conditions to slow hydrolysis.
| Property | Value | Notes |
|---|---|---|
| Main study model | Rodents, rats and mice | Underpins most of the published data |
| Common routes in studies | Subcutaneous, intraperitoneal, oral | Varies with the experimental design |
| Common analytical method | Reversed-phase HPLC, LC-MS | Used for identity and purity checks |
| Human evidence base | Small | Few trials reported, with limited findings |
| Regulatory status | Varies by jurisdiction | Not an approved medicine in most places |
Most early work on this peptide originated in the 1990s from a research group in Zagreb, Croatia, relying on animal models and cell cultures. Reported observations included effects on gastrointestinal lesion healing, tendon fibroblast migration, and blood vessel formation under controlled laboratory conditions. These findings come predominantly from rodent studies and in vitro assays rather than from human trials. Controlled human data remain limited, and the degree to which animal results translate to human physiology is an open question rather than a settled fact.
Within the research literature, the peptide is discussed through several provisional mechanisms, including cytoprotection, modulation of growth factor signaling, and interaction with the nitric oxide system. None of these mechanisms is fully characterized, and no single pathway is universally accepted. Review articles typically note the gap between consistent animal findings and sparse human evidence. The compound is classified as a research chemical rather than an approved pharmaceutical, which shapes how studies are designed, funded, and reported.
BPC-157 is a synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV, corresponding to a partial fragment of a larger protein detected in human gastric juice. The name derives from the parent protein designation BPC, an abbreviation of body protection compound, with 157 acting as a fraction or batch identifier used by the original investigators. Its molecular weight is approximately 1419 daltons, and the chain contains no unusual residues or disulfide bridges. In the literature it is described as a short, water-soluble fragment rather than a complete natural protein.
BPC-157 is a synthetic pentadecapeptide, meaning it consists of fifteen amino acids joined in a single chain. Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, a fragment corresponding to part of a larger protein found in human gastric juice. The peptide was first described in the 1990s by researchers in Zagreb who were studying gastric protective factors. It is not a naturally circulating hormone; it is a laboratory-made fragment derived from a stomach protein. The name is an abbreviation of body protection compound, with the number referring to the fragment's position in the source protein.
Most published work on BPC-157 comes from animal experiments rather than controlled human trials. Rodent models have examined its effects on gastrointestinal lesions, tendon and ligament injury, and blood vessel formation. These studies are often small and originate from a limited number of research groups, which affects how broadly the findings can be generalized. No large randomized human trial has been reported in the peer-reviewed literature. Discussion of the compound therefore rests largely on preclinical data, and questions about its effects in people remain open rather than settled.
Several mechanisms have been proposed to explain the activity observed in animal models. The most frequently cited involve signaling through vascular endothelial growth factor receptor 2 and modulation of the nitric oxide system. Researchers have also described interactions with protective pathways in the gut lining. These proposed mechanisms appear in the literature as hypotheses supported by preclinical observations, not as confirmed pathways in humans. The precise way the peptide produces its reported effects, and whether those effects carry across species, remain areas of active and unresolved investigation.
BPC-157 is a synthetic peptide composed of fifteen amino acids. Its sequence corresponds to part of a protein found in human gastric juice, which is the origin of the "body protection compound" label. In laboratory work the material is treated as a defined research chemical rather than a finished product. Published research has centered on animal models, and the peptide is not an approved medicine in most countries.
The peptide was first described in the early 1990s by a group studying gastric secretions and tissue repair. Its fifteen-residue chain is usually written as GEPPPGKPADDAGLV in single-letter code. The free peptide has the formula C62H98N16O22 and a theoretical mass near 1419.5 daltons. These identifiers are established chemical facts that can be checked against standard peptide databases. There is no ambiguity about the primary structure.
Most published findings come from rodent experiments using induced injury or surgical models. Human reports remain scarce and are largely observational, which limits how much can be stated with confidence. Questions about absorption, distribution, metabolism, and clearance in people are still open. Dose translation between species is likewise unresolved. Researchers tend to read the animal literature as a starting point rather than a settled account.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
==== Minnesota ==== In 2007, the Minnesota Department of Health lowered its Health Based Value for PFOA in drinking water from 1.0 ppb to 0.5 ppb, where "the sources are landfilled industrial wastes from a 3M manufacturing plant".
== Digestibility == Hemp protein, when untreated, is more digestible compared to soy protein. Heat pre-treatment at temperatures above 80 °C may improve the digestibility of both hemp and soy protein, but in untreated (unheated) form hemp protein is more readily digested than the soy one. Dehulled hemp seeds (also known as hemp nuts, hemp kernels or hemp hearts) have a protein digestibility corrected amino acid score (PDCAAS) of 0.66, with lysine being the limiting amino acid (digestibility of 92.1%). With its gluten content as low as 4.78 ppm, hemp is attracting attention as a gluten-free (<20 ppm) food material. Hemp protein is sold in bulk as a powder, in various forms, such as hempseed meal, hemp protein concentrates, and hemp protein isolates. It generally has greenish hue due to the natural pigments in the hemp plant, but the color can vary depending on the specific processing methods used. Unflavored hemp protein powder is commonly available, that is, no additional flavoring is added to the hemp protein, which is usually described as earthy or nutty.
On July 15, 2014, Researchers from the University of Essex both captured and delivered its graduation ceremonies in 4K UHDTV over the internet using H.264 in realtime. The 4K video stream was published at 8 Mbit/s and 14 Mbit/s for all its 11 ceremonies, with people viewing in from countries such as Cyprus, Bulgaria, Germany, Australia, UK, and others. On 4 September 2014, Canon Inc. announced that a firmware upgrade would add Rec. 2020 color space support to their EOS C500 and EOS C500 PL camera models and their DP-V3010 4K display. On 4 September 2014, Microsoft announced a firmware update for the Microsoft Lumia 1020, 930, Icon, and 1520 phones that adds 4K video recording. The update was later released by the individual phone carriers over the following weeks and months after the announcement. On September 5, 2014, the Blu-ray Disc Association announced that the 4K Blu-ray Disc specification supports 4K video at 60 fps, High Efficiency Video Coding, the Rec. 2020 color space, high dynamic range, and 10 bpc color depth. 4K Blu-ray Disc will have a data rate of at least 50 Mbit/s and may include support for 66 GB and 100 GB discs. 4K Blu-ray Disc began licensing in 2015, with 4K Blu-ray Disc players released late that year. On September 5, 2014, DigitalEurope released an Ultra HD logo for companies that meet their technical requirements. On September 11, 2014, satellite operator SES announced the first Ultra HD conditional access-protected broadcast using DVB standards at the IBC show in Amsterdam.
Sources: en.wikipedia.org
== Development == A cooperative Half-Life game was first alluded to by publisher Sierra On-Line in November 2000 with the announcement of a PlayStation 2 version of Half-Life. At the time, however, it was unclear how a cooperative version of Half-Life would be implemented; the developers, Gearbox Software, were still experimenting with finding the most balanced number of players to build a cooperative game around. By E3 2001, the game had acquired the title Decay, named after the scientific concept of exponential decay for consistency with the scientific names used by previous Half-Life titles. While the E3 convention only provided a demonstration of the main Half-Life PlayStation 2 game, further details were released relating to Decay's premise and story, as well as confirming that the cooperative mode was to be designed for two players. The game's use of new model sets were also showcased. These new models were updated versions of Gearbox's High Definition pack for Blue Shift, featuring higher numbers of polygons and animation features such as facial expressions. The enhanced models were around twice as detailed as those in the High Definition pack, which itself was of a much higher quality than the original models in Half-Life. Media updates through the months following E3 showed various screenshots and the trailer to the game. On August 18, 2001, Sierra announced that Decay was nearly complete, and would be submitted to PlayStation 2 manufacturer Sony for verification within days.
Rl = Xwαl/wRw + (1 − Xw)αl/sRs, where Rl, Rw, and Rs are the DHRs of lipids, water, and substrates, respectively. Xw is the mole fraction of lipid H derived from external water, whereas αl/w and αl/s denote the net isotopic fractionations associated with uptake and utilization of water and substrate hydrogen, respectively. For phototrophs, Rl is calculated assuming that Xw = 1. The isotopic fractionation between lipids and methane (αl/m) is 0.94 for fatty acids and 0.79 for isoprenoid lipids. The isotopic fractionation between lipids and water (αl/w) is 0.95 for fatty acids and 0.85 for isoprenoid lipids. For plants and algae, the isotopic fractionation between lipids and methane (αl/m) is 0.94 for fatty acids and 0.79 for isoprenoid lipids.
An urgent issue that had to be addressed was the economic crisis that began in 1974. Minister of Economy Fuentes Quintana proposed the signing of a great "social pact" that would "compensate" the harsh adjustment measures that had to be taken through social improvements and some juridical-political reforms. This led to the Moncloa Pacts signed on October 27, 1977, which succeeded in stabilizing the economy and controlling inflation ─ from 26.4% in 1977 to 16.5 the following year ─ and social spending was increased in return ─ unemployment benefits, pensions, education and health spending ─ thanks to the tax reform implemented by Minister Francisco Fernández Ordóñez. Another pressing matter was the "regional question", since the demands for self-government on the part of Catalonia and the Basque Country did not admit any further delay. In the case of Catalonia, the restoration of the Statute of Autonomy approved by the Republic was demanded, but Suárez opted to approve a decree-law of September 29, 1977, which "provisionally" restored the Generalitat although without reference to the 1932 Statute which allowed the return from exile of the "president" Josep Tarradellas. For the Basque Country, the Basque General Council was constituted in December 1977 under the presidency of the socialist Ramón Rubial, but as in the case of Catalonia, the Statute of Autonomy approved by the Republic was not reestablished either.
=== Temperature-responsive nanogels === The usage of thermoresponsive polymers in nanogel synthesis allows these systems to respond to changes in temperature. Depending on the chemical groups present, thermoresponsive polymers can either respond to a decrease in temperature or an increase in temperature. Both hydrophobic and hydrophilic groups are typically present in thermoresponsive polymer nanogels that react to temperature decreases, whereas nanogels that respond to temperature increases often have to be prepared by a hydrogen-bonded layering technique. Temperature-responsive nanogels are a potential strategy when a therapeutic is targeting the skin, which has a natural temperature gradient, or a region experiencing inflammation.
Sources: en.wikipedia.org
In Britain, a number of different filmmakers came together under John Grierson. They became known as the Documentary Film Movement. Grierson, Alberto Cavalcanti, Harry Watt, Basil Wright, and Humphrey Jennings amongst others succeeded in blending propaganda, information, and education with a more poetic aesthetic approach to documentary. Examples of their work include Drifters (John Grierson), Song of Ceylon (Basil Wright), Fires Were Started, and A Diary for Timothy (Humphrey Jennings). Their work involved poets such as W. H. Auden, composers such as Benjamin Britten, and writers such as J. B. Priestley. Among the best-known films of the movement are Night Mail and Coal Face. Calling Mr. Smith (1943) is an anti-Nazi color film created by Stefan Themerson which is both a documentary and an avant-garde film against war.
== Sources == Samuel W. Mitcham (2007). German Order of Battle. Volume Two: 291st–999th Infantry Divisions, Named Infantry Divisions, and Special Divisions in WWII. Stackpole Books. ISBN 978-0-8117-3437-0, p. 148–149. Georg Tessin: Verbände und Truppen der deutschen Wehrmacht und Waffen-SS im Zweiten Weltkrieg 1939–1945. Volume 11. Die Landstreitkräfte 501–630. Biblio-Verlag, Bissendorf 1975, ISBN 3-7648-1181-1, p. 128.
== Adverse effects == Adverse effects of doxycycline are similar to those of other members of the tetracycline antibiotic group. Doxycycline can cause gastrointestinal upset. Oral doxycycline can cause pill esophagitis, particularly when it is swallowed without adequate fluid, or by persons with difficulty swallowing or reduced gastrointestinal motility. Doxycycline is less likely than other antibiotic drugs to cause Clostridioides difficile colitis. An erythematous (red) rash in sun-exposed parts of the body has been reported to occur in 7.3–21.2% of persons taking doxycycline as prophylaxis against malaria. The rash resolves upon discontinuation of the drug. One study examined the tolerability of various malaria prophylactic regimens and found doxycycline did not cause a significantly higher percentage of skin events (such as rash, itching, or photosensitivity) when compared with other antimalarials. Unlike some other members of the tetracycline group, doxycycline may be used in those with renal impairment, because it is primarily excreted via the feces rather than the kidneys, and does not accumulate to toxic levels when kidney function is reduced. Doxycycline use has been associated with increased risk of inflammatory bowel disease. In one large retrospective study, patients who were prescribed doxycycline for their acne had a 2.25-fold greater risk of developing Crohn's disease.
Sources: en.wikipedia.org
Animal experiments form the bulk of the published record. Rodent models of tendon, ligament, bone, and gut injury are the most common designs. Controlled human trials are rare, which limits confidence in any clinical claim.
They are best described as working hypotheses. Supporting data come mainly from cell cultures and animal tissue, using markers such as growth factors and inflammatory signals. Confirmatory human studies have not been reported.
Status depends on the country. In some places it is treated as a research chemical available without a prescription, while elsewhere it falls under prescription or controlled rules. It holds no general marketing approval as a therapeutic product.
Lyophilised peptide powders are generally kept frozen or refrigerated, dry, and protected from light. Sealed vials limit moisture uptake and slow hydrolysis. Such guidance comes from general peptide chemistry rather than from stability studies specific to every product.